Comment on “Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy” by Intalapaporn et al.

2007 ◽  
Vol 55 (1) ◽  
pp. 90-91
Author(s):  
Prasad R. Koduri
2002 ◽  
Vol 13 (10) ◽  
pp. 724-726 ◽  
Author(s):  
Mark D King ◽  
Carl A Perlino ◽  
Jay Cinnamon ◽  
John A Jernigan

We report a case of paradoxical recurrent meningitis in response to initiation of highly active antiretroviral therapy in a patient receiving maintenance fluconazole for a previous diagnosis of cryptococcal meningitis. We describe the unusual radiographic and histopathologic findings which are consistent with an immune reconstitution induced paradoxical inflammatory response to residual cryptococcal infection.


2005 ◽  
Vol 16 (3) ◽  
pp. 187-189 ◽  
Author(s):  
Claude Fortin ◽  
Danielle Rouleau

A patient who developed an atypical manifestation ofMycobacterium aviumcomplex (MAC) infection almost two years after starting effective highly active antiretroviral therapy is described. The recurrence, manifested as brain abscesses in the central nervous system, was an uncommon form of MAC disease usually reported postmortem. An increased CD4 cell count, localized and suppurative infection, and the absence of systemic evidence of infection were consistent with a late immune reconstitution syndrome. The present case report adds to the understanding of MAC disease in HIV-infected patients.


2020 ◽  
Vol 66 (3) ◽  
pp. 22-26
Author(s):  
Tatyana B. Morgunova ◽  
Anastasia A. Zorina ◽  
Ekaterina S. Maloletkina ◽  
Yulia P. Sytch ◽  
Ariadna V. Vasileva ◽  
...  

The article focuses on the clinical case of Graves disease in a patient with HIV infection who is receiving antiretroviral therapy. The number of HIV-infected patients has increased significantly in recent decades all over the world. The currently used highly active antiretroviral therapy can significantly improve the prognosis for these patients. However, its use is associated with a number of complications, in particular the development of immune reconstitution syndrome, under which the development of such autoimmune diseases as Graves disease, polymyositis and Guillain-Barre syndrome may occur. Therefore, we would like to draw the attention of doctors to the possibility of such a complication in patients receiving antiretroviral therapy. Timely diagnosis and treatment of thyroid disorders will help to avoid the complications associated with an excess or deficit of thyroid hormones.


2020 ◽  
Vol 92 (7) ◽  
pp. 100-103
Author(s):  
A. A. Petrenko ◽  
G. A. Dudina ◽  
N. V. Kremneva ◽  
A. V. Pivnik

Here we provide a review of the literature and a description of our own clinical case. The patient was a 32-year-old woman who had been infected with HIV for 6 years without antiretroviral therapy. The test results showed CD4 87 cells/l, viral load 3750 copies/ml. Normochromic normocytic anemia and reticulocytopenia developed soon. In the myelogram, all erythroblasts were 0.5%. The viral load of parvovirus B19 DNA according to PCR was more than 9 million IU/ml. Pure red cell aplasia associated with parvovirus B19 was diagnosed. We started antiretroviral therapy with efavirenz, lamevudine and tenofovir. In addition to blood transfusions, we administered intravenous donor immunoglobulin with a dose increase from 5000 mg to 20 000 mg per day. After discontinuing of intravenous immunoglobulins, the laboratory test results were stable over the next 5 months: hemoglobin was more than 115 g/L, reticulocytes more than 3%, in the myelogram all erythroblasts were 21%. However, the elimination of parvovirus B19 wasnt achieved. The maximum decrease in viral load for parvovirus B19 was down to 720 IU/ml. A typical feature of the case was the lack of pure red cell aplasia of the bone marrow with the existing viral load of parvovirus B19. HIV infection progressed: 44 cells/l, viral load not determined. The case ended lethally.


Sign in / Sign up

Export Citation Format

Share Document